Clinical Trials Directory

Trials / Completed

CompletedNCT06758336

Caffeinated Chewing Gum & Wrestling Performance

Caffeinated Chewing Gum Improves Sympathetic Nerve Activity and Simulates Wrestling Performance: a Double-blind Crossover Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
National Taiwan Sport University · Academic / Other
Sex
Male
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to investigate the effect of caffeinated chewing gum on sympathetic nerve activity on wrestling simulation match.

Detailed description

The purpose of this study was to investigated whether caffeine intake is effective in improving the performance of wrestlers in a simulated competition. The study was designed to involve 16 healthy adult male athletes who had been trained in professional wrestling and were divided into caffeine trial (CAF trial) and placebo trial (PL trial) in a randomized crossover double-blind study design. After three days of dietary control, participants arrived at the laboratory in the afternoon of the day of the trial to collect saliva samples in a quiet state and were fitted with a heart rate monitor. Participants chewed either caffeine-containing gum at 3 mg/kg body weight (CAF trial) or placebo-containing gum without caffeine (PL trial) for 10 minutes and then spit it out. Participants then underwent a 15-minute dynamic warm-up. At the end of the warm-up, participants performed 2 rounds of 3-minute wrestling-specific simulated matches, and the number of falls in the simulated matches was recorded. After the simulation match, saliva samples were collected from the participants again. The saliva samples were analyzed for caffeine alpha-amylase concentration. Differences between the two trials were analyzed using a paired sample t-test and significance was set at α\<0.05.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTcaffeineThe participants chewing either caffeine Gum (CAF trial, containing 3 mg/kg of caffeine) for 10 minutes. After rested for 15 minutes, the participants underwent tests.

Timeline

Start date
2024-06-11
Primary completion
2024-06-30
Completion
2024-12-23
First posted
2025-01-03
Last updated
2025-01-03

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06758336. Inclusion in this directory is not an endorsement.